The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Exploratory biomarker analysis of ociperlimab (OCI) plus tislelizumab (TIS) in patients (pts) with PD-L1–positive non–small cell lung cancer (NSCLC) in AdvanTIG-105.
 
Yan Yu
No Relationships to Disclose
 
Yanyan Peng
Employment - BeOne Medicines
Stock and Other Ownership Interests - BeOne Medicines
 
Wei Tan
Employment - BeOne Medicines
Stock and Other Ownership Interests - BeOne Medicines
 
Guohua Yu
No Relationships to Disclose
 
Jun Zhang
Consulting or Advisory Role - AstraZeneca; Fosun Pharma; Novocure; Regeneron; Sanofi; Takeda
Speakers' Bureau - AstraZeneca; MJH Life Sciences; Regeneron; Sanofi
Research Funding - Abbvie (Inst); AstraZeneca; BeiGene (Inst); Bridgebio (Inst); Champions Oncology; Genentech/Roche; Hengrui Therapeutics (Inst); Innocare (Inst); Janssen (Inst); KAHR Medical (Inst); Lilly (Inst); Merck (Inst); Mirati Therapeutics; Mirati Therapeutics (Inst); Nilogen Oncosystems; Novartis (Inst); Takeda
 
Se Hyun Kim
No Relationships to Disclose
 
Han Yan
Employment - BeOne Medicines
 
Hanying Li
Employment - BeOne Medicines
 
Yun Zhang
Employment - BeOne Medicines
 
Zinan Bao
Employment - BeOne Medicines
Stock and Other Ownership Interests - BeOne Medicines
 
Yunxia Zuo
Employment - BeOne Medicines
Stock and Other Ownership Interests - BeOne Medicines
 
David Shames
Employment - BeOne Medicines; Genentech
Stock and Other Ownership Interests - BeOne Medicines; Lilly; Roche
Patents, Royalties, Other Intellectual Property - Multiple patents related to IO therapy
 
Shun Lu
Leadership - Innovent BIOLOGICS, INC; Shanghai Fosun; Simcere Zaiming
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; GenomiCare; Hutchison MediPharma; InventisBio Co. Ltd; Menarini; Pfizer; Roche; Simcere; Yuhan; Zai Lab
Speakers' Bureau - AstraZeneca; Hansoh Pharma; Hengrui Therapeutics; Roche
Research Funding - AstraZeneca (Inst); BeiGene (Inst); BMS (Inst); Hansoh (Inst); Hengrui Therapeutics (Inst); Hutchison MediPharma (Inst); Lilly Suzhou Pharmaceutical Co. (Inst); Roche (Inst)